126 related articles for article (PubMed ID: 19077081)
1. Reactivation of hepatitis B two years after rituximab therapy in a renal transplant patient with recurrent focal segmental glomerulosclerosis: a note of caution.
Gossmann J; Scheuermann EH; Kachel HG; Geiger H; Hauser IA
Clin Transplant; 2009; 23(3):431-4. PubMed ID: 19077081
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis B virus reactivation in lymphoma patients with prior resolved hepatitis B undergoing anticancer therapy with or without rituximab.
Yeo W; Chan TC; Leung NW; Lam WY; Mo FK; Chu MT; Chan HL; Hui EP; Lei KI; Mok TS; Chan PK
J Clin Oncol; 2009 Feb; 27(4):605-11. PubMed ID: 19075267
[TBL] [Abstract][Full Text] [Related]
3. Rituximab and chronic plasmapheresis therapy of nephrotic syndrome in renal transplantation patients with recurrent focal segmental glomerulosclerosis.
RodrÃguez-Ferrero M; Ampuero J; Anaya F
Transplant Proc; 2009; 41(6):2406-8. PubMed ID: 19715934
[TBL] [Abstract][Full Text] [Related]
4. Immunoadsorbtion and rituximab therapy in a second living-related kidney transplant patient with recurrent focal segmental glomerulosclerosis.
Meyer TN; Thaiss F; Stahl RA
Transpl Int; 2007 Dec; 20(12):1066-71. PubMed ID: 17887957
[TBL] [Abstract][Full Text] [Related]
5. Abrogation of nephrotic proteinuria by rituximab treatment in a renal transplant patient with relapsed focal segmental glomerulosclerosis.
Gossmann J; Scheuermann EH; Porubsky S; Kachel HG; Geiger H; Hauser IA
Transpl Int; 2007 Jun; 20(6):558-62. PubMed ID: 17433091
[TBL] [Abstract][Full Text] [Related]
6. Use of rituximab in focal glomerulosclerosis relapses after renal transplantation.
Dello Strologo L; Guzzo I; Laurenzi C; Vivarelli M; Parodi A; Barbano G; Camilla R; Scozzola F; Amore A; Ginevri F; Murer L
Transplantation; 2009 Aug; 88(3):417-20. PubMed ID: 19667947
[TBL] [Abstract][Full Text] [Related]
7. Combination treatment with plasmapheresis and rituximab for recurrent focal segmental glomerulosclerosis after renal transplantation.
Tsagalis G; Psimenou E; Nakopoulou L; Laggouranis A
Artif Organs; 2011 Apr; 35(4):420-5. PubMed ID: 20637013
[TBL] [Abstract][Full Text] [Related]
8. High risk of hepatitis B-virus reactivation after hematopoietic cell transplantation in hepatitis B core antibody-positive patients.
Matsue K; Aoki T; Odawara J; Fujiwara H; Iwama K; Kimura S; Yamakura M; Takeuch M
Eur J Haematol; 2009 Oct; 83(4):357-64. PubMed ID: 19508685
[TBL] [Abstract][Full Text] [Related]
9. The effectiveness of lamivudine in preventing hepatitis B viral reactivation in rituximab-containing regimen for lymphoma.
He YF; Li YH; Wang FH; Jiang WQ; Xu RH; Sun XF; Xia ZJ; Huang HQ; Lin TY; Zhang L; Bao SP; He YJ; Guan ZZ
Ann Hematol; 2008 Jun; 87(6):481-5. PubMed ID: 18299831
[TBL] [Abstract][Full Text] [Related]
10. Rituximab for post-transplant recurrences of FSGS.
Bayrakci US; Baskin E; Sakalli H; Karakayali H; Haberal M
Pediatr Transplant; 2009 Mar; 13(2):240-3. PubMed ID: 18822107
[TBL] [Abstract][Full Text] [Related]
11. Protocol biopsies for focal segmental glomerulosclerosis treated with plasma exchange and rituximab in a renal transplant patient.
Sakai K; Takasu J; Nihei H; Yonekura T; Aoki Y; Kawamura T; Mizuiri S; Aikawa A
Clin Transplant; 2010 Jul; 24 Suppl 22():60-5. PubMed ID: 20590697
[TBL] [Abstract][Full Text] [Related]
12. Interferon-alpha-induced focal segmental glomerulosclerosis in chronic myelogenous leukemia: a case report and review of the literature.
Bremer CT; Lastrapes A; Alper AB; Mudad R
Am J Clin Oncol; 2003 Jun; 26(3):262-4. PubMed ID: 12796597
[TBL] [Abstract][Full Text] [Related]
13. Fatal reactivation of hepatitis B virus in a patient who was hepatitis B surface antigen negative and core antibody positive before receiving chemotherapy for non-Hodgkin lymphoma.
Wu JM; Huang YH; Lee PC; Lin HC; Lee SD
J Clin Gastroenterol; 2009; 43(5):496-8. PubMed ID: 19247200
[TBL] [Abstract][Full Text] [Related]
14. Lamivudine for the prevention of hepatitis B virus reactivation after high-dose chemotherapy and autologous hematopoietic stem cell transplantation for patients with advanced or relapsed non-Hodgkin's lymphoma single institution experience.
Huang H; Cai Q; Lin T; Lin X; Liu Y; Gao Y; Peng R
Expert Opin Pharmacother; 2009 Oct; 10(15):2399-406. PubMed ID: 19761353
[TBL] [Abstract][Full Text] [Related]
15. Focal segmental glomerulosclerosis as a complication of hepatitis B virus infection.
Sakai K; Morito N; Usui J; Hagiwara M; Hiwatashi A; Fukuda K; Nanmoku T; Toda T; Matsui N; Nagata M; Yamagata K
Nephrol Dial Transplant; 2011 Jan; 26(1):371-3. PubMed ID: 20959346
[TBL] [Abstract][Full Text] [Related]
16. Reactivation of hepatitis B virus with rituximab.
Tsutsumi Y; Kanamori H; Mori A; Tanaka J; Asaka M; Imamura M; Masauzi N
Expert Opin Drug Saf; 2005 May; 4(3):599-608. PubMed ID: 15934864
[TBL] [Abstract][Full Text] [Related]
17. Successful treatment of recurrent focal segmental glomerulosclerosis after kidney transplantation by plasmapheresis and rituximab.
Hristea D; Hadaya K; Marangon N; Buhler L; Villard J; Morel P; Martin PY
Transpl Int; 2007 Jan; 20(1):102-5. PubMed ID: 17181660
[TBL] [Abstract][Full Text] [Related]
18. Rituximab in minimal change nephropathy and focal segmental glomerulosclerosis: report of four cases and review of the literature.
Peters HP; van de Kar NC; Wetzels JF
Neth J Med; 2008 Nov; 66(10):408-15. PubMed ID: 19011266
[TBL] [Abstract][Full Text] [Related]
19. High-titer antibody to hepatitis B surface antigen before liver transplantation can prevent de novo hepatitis B infection.
Su WJ; Ho MC; Ni YH; Chen HL; Hu RH; Wu YM; Chang MH; Lee PH
J Pediatr Gastroenterol Nutr; 2009 Feb; 48(2):203-8. PubMed ID: 19179883
[TBL] [Abstract][Full Text] [Related]
20. Resolution of recurrent focal segmental glomerulosclerosis proteinuria after rituximab treatment.
Pescovitz MD; Book BK; Sidner RA
N Engl J Med; 2006 May; 354(18):1961-3. PubMed ID: 16672715
[No Abstract] [Full Text] [Related]
[Next] [New Search]
